🔥Is response associated with OS in #HCC❓ 👉Our post-hoc analysis of REFELCT Journal of Hepatology doi.org/10.1016/j.jhep… ✅mOS twice as long in responders vs non-responders 👇PR vs SD vs PD 🔥Lenvatinib valid option in 1st line ->LEAP-02 EASL Education #LiverTwitter ESMO - Eur. Oncology OncoAlert

thelancet.com/journals/lanon… The field of systemic treatments for #HCC is expanding, as well as controversies on RCTs interpretation. We discuss surrogate endpoints, downstream therapies and patient selection on The Lancet Oncology w/Giuseppe Cabibbo David James Pinato 🇺🇦 Antonio D'Alessio Claudia Angela M. Fulgenzi

Inspiring faculty at the 2nd AISF - Associazione Italiana Studio Fegato training day in #Rome Prof Cammà showing the complexity behind #surrogates #endpoint in #HCC Prof. De Franchis and Prof. Vincenza Calvaruso pointing out the history of #Baveno and what’s new in @BavenoVII PROMISE-UNIPA-HCC Group, #unipa

Former italian health minister Beatrice Lorenzin pointing the importance of using #DAAs against #HCV to prevent #hepatocellularcarcinoma The Italian experience PROMISE-UNIPA-HCC Group Giuseppe Cabibbo Ciro Celsa #LiverCancerAwarenessMonth

#HCC Sicily network. The Sicilian #Gastroenterology school in Rome

I'm happy to share our new review discussing the evolving scenario in the assessment of radiological response for hepatocellular carcinoma in the era of #Immunotherapy! Paolo Giuffrida Ciro Celsa Giuseppe Cabibbo PROMISE-UNIPA-HCC Group Find out more: mdpi.com/2227-9059/10/1…

BCLC 2022 update. Discussing outcomes in advanced HCC with Jordi Bruix Maria Reig Lorenza Rimassa Jordi Rimola and Roman Kloeckner

Glad to be presenting a clincal case of #PancreaticCancer and to witness an amazing Prof. Marco Giovannini performing #EUS guided #hepaticogastrostomy at #endoboat #pentaxmedical

linkedin.com/feed/update/ur…

It was a pleasure to comment with Julien Edeline, on the study by Talbot et al Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma. onlinelibrary.wiley.com/doi/epdf/10.11… onlinelibrary.wiley.com/doi/10.1111/li…

Innovative data presented by an outstanding Ciro Celsa at #AISF2023 AISF - Associazione Italiana Studio Fegato PROMISE-UNIPA-HCC Group

Good luck to the new AISF - Associazione Italiana Studio Fegato Secretary Congratulations Prof.Vincenza Calvaruso #promiseUNIPA UniPa

The word Alliance will improve patient care & cure! This joint conference #gastroenterology + #endoscopy + #radiology organized by AISP on #PancreaticCancer is the way to go Honored to be Faculty with Piero Boraschi Roberto Cannella Giulia Zamboni Tommaso Bartolotta Paolo Giuffrida

Stiamo andando verso una #sanità "a doppio binario” con l’aggravante che le Regioni del Sud rischiano di diventare clienti di quelle del Nord #SalviamoSSN lanotiziagiornale.it/autonomia-diff…

At #ENDOBOAT2023, Prof. Fusaroli shows how to perform #EUS guided tissue acquisition of pancreatic lesion. Thanks to the Vivascope technology, #anatomopathologists make immediate diagnosis of #PDAC #Forli #endoscopy #EUS

Amazing hands on training at #ESGEDays2023 on #endoscopic hemostasis. Thanks to Balint Eross for being such a great trainer and for all the tips and tricks ESGE Pietro Graceffa

Good RCTs of EUS-BD vs ERCP finally coming out. gastrojournal.org/article/S0016-…

Happy to share our latest publication online in Endoscopy Journal 😇 "Bleeding giant pseudoaneurysm non-visualized on arterial phase imaging: Endoscopic ultrasound-guided angioembolization to the rescue" 🥰 Jayanta Samanta Antriksh Pankaj Gupta

Prima giornata del corso AISP lesioni cistiche e solide del pancreas a Palermo Piero Boraschi Giulia Zamboni Federica Vernuccio Gabriele Capurso MD, PhD🇺🇦 Paolo Giuffrida

Great energy in Palermo for this first day of AISP meeting for the management of #pancreatic cystic lesions. #guidelines, pitfalls, mistakes and way to improve our daily clinical practice Thanks to #AISP for such a great work